Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study.
Shuji IkegamiMasanao NakamuraTakashi HondaTakeshi YamamuraKeiko MaedaTsunaki SawadaEri IshikawaKenta YamamotoSatoshi FuruneTakuya IshikawaKazuhiro FurukawaEizaburo OhnoMasatoshi IshigamiFumie KinoshitaYoshihiro KadotaTakumi TochioYoshiharu ShimomuraYoshiki HirookaHiroki KawashimaPublished in: Alimentary pharmacology & therapeutics (2023)
Oral 1-kestose is well tolerated and provides clinical improvement for patients with mild to moderate ulcerative colitis through modulation of the gut microbiome.